Deuruxolitinib

deuruxolitinib · Sun Pharmaceutical Industries, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Deuruxolitinib, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata [Phase 3]